Traditional pacemakers are composed of electronic circuits with batteries and leads anchored to the heart muscle to stimulate it. However, the leads can fail and damage tissue, and their location cannot be changed once implanted. Additionally, the rigid, metallic electrodes used in conventional pacemakers may cause tissue damage when restarting the heart after surgery or regulating arrhythmia.
The team behind the ultrathin pacemaker envisioned a leadless and more flexible device that could precisely stimulate multiple areas of the heart. By transforming light into bioelectricity, or heart cell-generated electrical signals, the pacemaker is able to regulate heartbeats with greater precision. The device is thinner than a human hair and made of an optic fiber and silicon membrane, allowing for minimally invasive implantation without the need to open the chest.
The ultrathin pacemaker gently conforms to the surface of the heart, enabling less invasive stimulation and improved pacing and synchronized contraction. It has the potential to reduce postoperative trauma and recovery time, making it an ideal solution for urgent heart conditions such as restarting the heart after surgery, heart attacks, and ventricular defibrillation. The successful implantation of the device in both rodents and adult pigs demonstrates its potential to translate to human patients.
Despite its promising benefits, the long-term effects and durability of the pacemaker in the human body remain a topic of ongoing research. The body’s internal environment, rich in fluids and subject to constant mechanical motion, poses challenges for the device’s functionality over time. Scar tissue formation and rejection of the device are also concerns that need to be addressed through special surface treatments and biomaterial coatings.
The research team is working on refining the rate at which the pacemaker dissolves naturally in the body to achieve long-term implantation. They are also exploring enhancements to make the device compatible as a wearable pacemaker, integrating a wireless light-emitting diode beneath the skin connected to the device via an optical fiber. The ultimate goal is to expand the application of this technology beyond cardiac care to include neurostimulation, neuroprostheses, and pain management for neurodegenerative conditions like Parkinson’s disease.
The development of the wireless, ultrathin pacemaker represents a significant advancement in cardiac care. By harnessing the power of light, this innovative device offers a more precise and less invasive alternative to traditional pacemakers. As further research and development are carried out, the potential for this technology to revolutionize not only cardiac care but also other areas of medical treatment is immense.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookies
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.
Leave a Reply